Acute pancreatitis associated with lamivudine therapy for chronic B hepatitis

Abstract

Hyperamylasemia is a common complication during lamivudine use. We report a case of a pancreatitis following lamivudine therapy. A careful monitoring of amylase levels during treatment with lamivudine is discussed, mainly in the first weeks, considering the cost of this exam and further complication.

Keywords

• Lamivudine
• pancreatitis
• amylases
• hyperamilasemina
• hepatitis
• chronic B hepatitis